211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
The Readout Loud
00:00
Bluebird Therapy
Bluebird is a company that has always excelled at the science of jean therapy. The actual nature of how these approvals will take shape, i mean, still remains to be seen. Some gentheripy companies are moving on from very rare and quite often fatal diseases into things where they may be debilitating, but not necessarily life threatening. And that changes the calculus from the fda perspective as well.
Transcript
Play full episode
